Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States.
$2.79-9.71%
报价 2026-11-06
市值
$30.3M
EV
$28.8M
PE (TTM)
27.6x
预期 PE (FY2026)
62.0x
52 周区间距高点 -51.8%
$2.78$5.79
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NEPHNephros, Inc. | $30.3M | -9.7% | +11.4% | 61.1% | 27.6x | 22.4x | 18.4x | |
| SPRBSpruce Biosciences, Inc. | $133.8M | +9.0% | +2590.0% | 0% | – | – | – | |
| OTLKOutlook Therapeutics, Inc. | $106.2M | -0.6% | +173.6% | 195.6% | – | – | – | |
| NRXPNRx Pharmaceuticals, Inc. | $103M | +4.8% | +800.8% | 32.7% | – | – | – | |
| ICCCImmuCell Corporation | $89M | -1.5% | 0.0% | 40.3% | 127.5x | 28.6x | 23.2x | |
| DXRDaxor Corporation | $49.3M | -2.1% | +7856.1% | -57.5% | 5.8x | 5.6x | 292.1x | |
| HOWLWerewolf Therapeutics, Inc. | $49.1M | -1.0% | +232.0% | 86.4% | – | – | – | |
| OSTXOS Therapies Incorporated | $46.8M | +2.0% | -84.7% | 0% | – | – | – | |
| ONMDOneMedNet Corporation | $29.9M | +23.3% | – | -68.8% | – | – | – | |
| 同行中位数 | – | – | +232.0% | 16.3% | 66.7x | 17.1x | 157.7x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。